当前位置:Public Access >页面
Chinese/English
Recombinant human thrombopoietin (rhTPO) combined with granulocyte colony stimulating factor (G-CSF) for autologous peripheral blood stem cell morbiliztion, a prospective, randomized, multicentric phase II clinical trial

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR-IIR-17010787

研究题目:

Recombinant human thrombopoietin (rhTPO) combined with granulocyte colony stimulating factor (G-CSF) for autologous peripheral blood stem cell morbiliztion, a prospective, randomized, multicentric phase II clinical trial

Study title:

Recombinant human thrombopoietin (rhTPO) combined with granulocyte colony stimulating factor (G-CSF) for autologous peripheral blood stem cell morbiliztion, a prospective, randomized, multicentric phase II clinical trial

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

13386259777

电子邮件

Email

wangchunmd@163.com

通讯地址:

上海市虹口区海宁路100号

Address:

No.100 Haining Road, Hongkou district,Shanghai, China

邮政编码

Postcode

210000

项目负责人所有单位:

上海市第一人民医院

Institution:

Shanghai General Hosptial

批准本研究的伦理委员会名称:

上海市第一人民医院医学伦理委员会

Name of the ethic committee:

The Medical Ethics Committee of Shanghai General H

研究疾病:

Study Ailment:

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Diagnostic Accuracy Test

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

上海

市(区县):

上海

Country/Area:

PR China

Province:

Shanghai

City:

Shanghai
单位 上海市第一人民医院
Institution Shanghai General Hospital

预计起止时间:

Planned Duration:

2010/4/1 0:00:00-2011/4/1 0:00:00